(PX) P10 - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US69376K1060

PX: Private Equity, Venture Capital, Impact Investing, Private Credit

P10, Inc. (NYSE: PX) is a leading provider of multi-asset class private market solutions in the alternative asset management industry, specializing in private equity, venture capital, impact investing, and private credit. The company offers a diverse range of investment strategies, including primary fund of funds, secondary investments, and direct and co-investments. Its private equity solutions are marketed under the RCP Advisors, Bonaccord Capital, and P10 Advisors brands, while its venture capital offerings are managed under the TrueBridge brand. Impact investing solutions are provided under the Enhanced brand, and private credit solutions are offered through the Five Points, Hark Capital, and WTI brands. Headquartered in Dallas, Texas, P10, Inc. was established in 1992 and has grown into a prominent player in the alternative asset management sector.

From a technical perspective, PX has shown stability with a 20-day average volume of 507,850 shares. The stock is currently trading at $11.57, slightly above its 20-day SMA of $10.76 but closely aligned with its 50-day SMA of $11.46 and 200-day SMA of $11.58. The Average True Range (ATR) of 0.52 indicates moderate volatility. On the fundamental side, P10, Inc. has a market capitalization of $1.243 billion, with a trailing P/E of 68.88 and a forward P/E of 11.92, suggesting potential valuation adjustments. The price-to-book ratio stands at 3.58, and the price-to-sales ratio is 4.20, while the return on equity is 5.39%.

3-Month Forecast: - Technical Outlook: PX is expected to trade within a narrow range, with support near $10.76 (20-day SMA) and resistance at $11.58 (200-day SMA). The ATR of 0.52 suggests minimal price fluctuations. - Fundamental Analysis: The forward P/E of 11.92 indicates potential upside as earnings estimates are factored in, though the current P/E of 68.88 may signal short-term pressure. - Overall Forecast: PX is likely to remain range-bound in the near term, with potential for modest upside if fundamental improvements align with technical support levels.

Additional Sources for PX Stock

PX Stock Overview

Market Cap in USD 1,297m
Sector Financial Services
Industry Asset Management
GiC Sub-Industry Asset Management & Custody Banks
IPO / Inception 2021-10-21

PX Stock Ratings

Growth Rating 60.5
Fundamental 30.7
Dividend Rating 64.0
Rel. Strength 27.8
Analysts 3.8/5
Fair Price Momentum 11.36 USD
Fair Price DCF 17.38 USD

PX Dividends

Dividend Yield 12m 1.23%
Yield on Cost 5y 4.84%
Annual Growth 5y 15.31%
Payout Consistency 100.0%

PX Growth Ratios

Growth Correlation 3m -74.2%
Growth Correlation 12m 73.6%
Growth Correlation 5y 30.7%
CAGR 5y 32.29%
CAGR/Max DD 5y 0.57
Sharpe Ratio 12m 2.05
Alpha 42.26
Beta 1.550
Volatility 34.55%
Current Volume 614.1k
Average Volume 20d 460.7k
What is the price of PX stocks?
As of May 09, 2025, the stock is trading at USD 11.72 with a total of 614,074 shares traded.
Over the past week, the price has changed by +3.99%, over one month by +21.96%, over three months by -13.65% and over the past year by +56.45%.
Is P10 a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, P10 is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 30.71 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PX as of May 2025 is 11.36. This means that PX is currently overvalued and has a potential downside of -3.07%.
Is PX a buy, sell or hold?
P10 has received a consensus analysts rating of 3.80. Therefor, it is recommend to hold PX.
  • Strong Buy: 1
  • Buy: 2
  • Hold: 2
  • Sell: 0
  • Strong Sell: 0
What are the forecast for PX stock price target?
According to ValueRays Forecast Model, PX P10 will be worth about 12.9 in May 2026. The stock is currently trading at 11.72. This means that the stock has a potential upside of +10.07%.
Issuer Forecast Upside
Wallstreet Target Price 14.2 21.2%
Analysts Target Price 14.3 22%
ValueRay Target Price 12.9 10.1%